Stay updated with breaking news from Nasdaq Ocup. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocuphire Pharma (NASDAQ:OCUP – Get Free Report) released its earnings results on Friday. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.23) by ($0.01), MarketWatch Earnings reports. The business had revenue of $3.67 million during the quarter. Ocuphire Pharma Trading Up 1.9 % OCUP traded up $0.08 during […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Free Report)’s stock price dropped 3.4% during mid-day trading on Tuesday . The stock traded as low as $3.99 and last traded at $4.01. Approximately 83,493 shares traded hands during trading, a decline of 68% from the average daily volume of 259,036 shares. The stock had previously closed at […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) was the target of a significant decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,540,000 shares, a decline of 24.5% from the May 15th total of 2,040,000 shares. Based on an average trading volume of 374,900 shares, the […]
Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) – Analysts at Cantor Fitzgerald decreased their FY2023 earnings per share estimates for shares of Ocuphire Pharma in a report issued on Tuesday, May 16th. Cantor Fitzgerald analyst K. Kluska now expects that the company will post earnings of ($0.69) per share for the year, down from their […]
Lincoln National Corp purchased a new position in shares of Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,600 shares of the company’s stock, valued at approximately $41,000. Lincoln National Corp […]